2022
DOI: 10.3389/fnbeh.2022.842184
|View full text |Cite
|
Sign up to set email alerts
|

Deep Brain Stimulation of the Nucleus Accumbens in Severe Enduring Anorexia Nervosa: A Pilot Study

Abstract: IntroductionAnorexia nervosa (AN) is one of the most debilitating psychiatric disorders, becoming severe and enduring in a third of cases; with few effective treatments. Deep brain stimulation is a reversible, adjustable neurosurgical procedure that has been gaining ground in psychiatry as a treatment for depression and obsessive–compulsive disorder, yet few studies have investigated AN. Abnormal eating behavior and the compulsive pursuit of thinness in AN is, in part, a consequence of dysfunction in reward ci… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 72 publications
(99 reference statements)
0
6
0
Order By: Relevance
“…In the selection of a subset of participants from the Anorexia Nervosa Genetics Initiative (ANGI) to include in their assessment of the polygenic association of severity and long-term outcome in AN, Johansson et al [ 50 ] included in their criteria for the severe enduring subtype a ≥ 5 year follow-up time, defined by the authors as years between initial registration and ANGI recruitment. Finally, in two of the three studies evaluating the effectiveness of deep brain stimulation, an illness duration of ≥ 10 years was required for participant inclusion [ 51 , 52 ], with the third requiring > 7 years [ 53 ]. Case study, clinical trial and study participants included in groups indicated as manifesting a severe and enduring phenotype tended to have illness of longer duration.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the selection of a subset of participants from the Anorexia Nervosa Genetics Initiative (ANGI) to include in their assessment of the polygenic association of severity and long-term outcome in AN, Johansson et al [ 50 ] included in their criteria for the severe enduring subtype a ≥ 5 year follow-up time, defined by the authors as years between initial registration and ANGI recruitment. Finally, in two of the three studies evaluating the effectiveness of deep brain stimulation, an illness duration of ≥ 10 years was required for participant inclusion [ 51 , 52 ], with the third requiring > 7 years [ 53 ]. Case study, clinical trial and study participants included in groups indicated as manifesting a severe and enduring phenotype tended to have illness of longer duration.…”
Section: Resultsmentioning
confidence: 99%
“… Does not propose criteria Does not propose criteria Does not propose criteria Does not propose criteria 29. [ 53 ] Scaife et al, 2022 Study evaluating efficacy of DBS in those with SE-AN Deep brain stimulation of the nucleus accumbens in severe enduring anorexia nervosa: A pilot study. Inclusion criteria:>13, < 16 Inclusion criteria:>7 Inclusion criteria: ≥3 voluntary intensive treatments (partial or full hospitalization) and ≥2 trials of psychological treatment Various tools used though not to define SE-AN 30.…”
Section: Methodsmentioning
confidence: 99%
“…In our review, we identified multiple studies assessing the efficacy of DBS for the treatment of AN. While there exists variability in results, with some studies reporting a stable BMI [ 101 , 114 , 116 ], the vast majority reported improvements in BMI, with none reporting a decline ( Table 3 ). Notably, we did not identify studies utilizing DBS for the treatment of BN, representing a potential future direction for investigation.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, it should be noted that while most studies reported significant weight restoration and improvement in ratings of comorbid symptoms (i.e., depression, OCD, and anxiety), QoL improvement is less certain. Most studies did not provide strict metrics for QoL, although it is worth noting that among those that did [ 103 , 106 , 116 , 117 ], all but De Vloo et al found improvements in such measures [ 115 ]. In reference to their findings, De Vloo et al suggested that an early post-operative placebo effect and expectation bias could contribute to more positive short-term results which diminish in the long term [ 115 ].…”
Section: Current Neuromodulatory Options and Their Target Network/nodesmentioning
confidence: 99%
“…Studies on DBS in AN have explored diverse targets including the subcallosal cingulate cortex (SCC), nucleus accumbens (NAcc) and ventral anterior limb of the internal capsule (vALIC) [ 1 , 3 6 ]. Interestingly, different targets have shown comparable clinical effects, suggesting that DBS is effective at different targets and normalizes wider aberrant network activity in the brain.…”
Section: Introductionmentioning
confidence: 99%